Literature DB >> 29045049

Germinal Center B Cells Are Essential for Collagen-Induced Arthritis.

Albert Dahdah1, Katrin Habir1, Kutty Selva Nandakumar2, Amit Saxena1, Bingze Xu1, Rikard Holmdahl1, Stephen Malin1.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is considered to be a prototypical autoimmune disorder. Several mechanisms have been proposed for the known pathologic function of B cells in RA, including antigen presentation, cytokine secretion, and humoral immunity. The aim of this study was to address the function of B lymphocytes in experimental arthritis.
METHODS: We mapped the adaptive immune response following collagen-induced arthritis (CIA). We subsequently monitored these responses and disease outcomes in genetically modified mouse strains that lack mature B cell or germinal center (GC) functionality in a B cell-intrinsic manner.
RESULTS: Following primary immunization, the draining lymph nodes broadly reacted against type II collagen (CII) with the formation of GCs and T cell activation. Mice that lacked mature B cell function were fully protected against CIA and had a severely attenuated ability to mount isotype-switched humoral immune responses against CII. Almost identical results were observed in mice that were selectively deficient in GC responses. Importantly, GC-deficient mice were fully susceptible to collagen antibody-induced arthritis.
CONCLUSION: We identified GC formation and anticollagen antibody production as the key pathogenic functions of B cells in CIA. The role of B cells in RA is likely to be more complex. However, targeting the GC reaction could allow for therapeutic interventions that are more refined than general B cell depletion.
© 2017, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29045049     DOI: 10.1002/art.40354

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  18 in total

1.  Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis.

Authors:  Yawei Tang; Ziran Bai; Jingjing Qi; Zhimin Lu; Guan Wang; Minli Jin; Bing Wang; Haifeng Chen; Xia Li
Journal:  Clin Exp Immunol       Date:  2021-10-05       Impact factor: 4.330

2.  Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis.

Authors:  Hui Wang; Xiaofei Li; Tetsuhiro Kajikawa; Jieun Shin; Jong-Hyung Lim; Ioannis Kourtzelis; Kosuke Nagai; Jonathan M Korostoff; Sylvia Grossklaus; Ronald Naumann; Triantafyllos Chavakis; George Hajishengallis
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

3.  Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis.

Authors:  Monica Centa; Kajsa E Prokopec; Manasa G Garimella; Katrin Habir; Lisa Hofste; Julian M Stark; Albert Dahdah; Chris A Tibbitt; Konstantinos A Polyzos; Anton Gisterå; Daniel K Johansson; Nobuyo N Maeda; Göran K Hansson; Daniel F J Ketelhuth; Jonathan M Coquet; Christoph J Binder; Mikael C I Karlsson; Stephen Malin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

4.  Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.

Authors:  Zemin Lin; Yuting Liu; Li Chen; Shiqi Cao; Yueteng Huang; Xiaoqian Yang; Fenghua Zhu; Wei Tang; Shijun He; Jianping Zuo
Journal:  Sci China Life Sci       Date:  2021-01-19       Impact factor: 6.038

5.  Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal.

Authors:  Mattias N D Svensson; Martina Zoccheddu; Shen Yang; Gyrid Nygaard; Christian Secchi; Karen M Doody; Kamil Slowikowski; Fumitaka Mizoguchi; Frances Humby; Rebecca Hands; Eugenio Santelli; Cristiano Sacchetti; Kuninobu Wakabayashi; Dennis J Wu; Christopher Barback; Rizi Ai; Wei Wang; Gary P Sims; Piotr Mydel; Tsuyoshi Kasama; David L Boyle; Francesco Galimi; David Vera; Michel L Tremblay; Soumya Raychaudhuri; Michael B Brenner; Gary S Firestein; Costantino Pitzalis; Anna-Karin H Ekwall; Stephanie M Stanford; Nunzio Bottini
Journal:  Sci Adv       Date:  2020-06-26       Impact factor: 14.136

6.  Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis.

Authors:  Maria J Gutierrez; Stephen V Desiderio; Nae-Yuh Wang; Erika Darrah; Laura Cappelli; Gustavo Nino; Michelle Jones; Clifton O Bingham
Journal:  J Immunol Res       Date:  2019-04-28       Impact factor: 4.818

7.  The oncoprotein TBX3 is controlling severity in experimental arthritis.

Authors:  Samra Sardar; Alish Kerr; Daniëlle Vaartjes; Emilie Riis Moltved; Edita Karosiene; Ramneek Gupta; Åsa Andersson
Journal:  Arthritis Res Ther       Date:  2019-01-10       Impact factor: 5.156

Review 8.  Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis.

Authors:  Qinghua Fang; Jiaxin Ou; Kutty Selva Nandakumar
Journal:  Mediators Inflamm       Date:  2019-10-27       Impact factor: 4.711

9.  Self-reactive T cells induce and perpetuate chronic relapsing arthritis.

Authors:  Jonatan Tuncel; Jens Holmberg; Sabrina Haag; Malin Hultqvist Hopkins; Lena Wester-Rosenlöf; Stefan Carlsen; Peter Olofsson; Rikard Holmdahl
Journal:  Arthritis Res Ther       Date:  2020-04-28       Impact factor: 5.156

10.  Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses.

Authors:  Saikiran K Sedimbi; Thomas Hägglöf; Manasa G Garimella; Shan Wang; Amanda Duhlin; Ana Coelho; Katrine Ingelshed; Emma Mondoc; Stephen G Malin; Rikard Holmdahl; David P Lane; Elizabeth A Leadbetter; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.